Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

European Patient Summary

Patient
Name: Comboni, Ignazio
DOB: 25-OCT-1961 (Age: 64)
Gender: male
ID: 9078-308345-5 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 18-JUN-2025

Problem list

Condition Onset Date Status
Non-small cell lung cancer 14-Nov-2024 active
Anemia 14-Nov-2024 active
Neoplasm of prostate 29-Mar-2023 active
Metastasis from malignant tumor of prostate 29-Mar-2023 active
Ischemic heart disease 04-Mar-2020 active
Gout 31-May-1986 active
Major depressive disorder 21-Feb-1979 active
Chronic sinusitis 26-May-1974 active

Medication list

No known medications

Immunizations list

Vaccine Date
Streptococcus pneumoniae Danish serotype 1 02-Apr-2025
Influenza virus antigen only vaccine product 30-Oct-2024
SARS-CoV-2 mRNA vaccine 14-Apr-2021
Clostridium tetani toxoid antigen adsorbed only vaccine product 10-Mar-2021

Procedure History list

Procedure Date Reason
Hearing examination 22-Jun-2025 -
Combined chemotherapy and radiation therapy 22-Jun-2025 Non-small cell carcinoma of lung TNM stage 1 (disorder)
Suture open wound 20-May-2025 Laceration of foot
High resolution computed tomography of chest without contrast 11-Apr-2025 -
Patient discharge 24-Feb-2025 -
Hospice care 23-Feb-2025 -
Notifications 15-Jan-2025 -
Certification procedure 15-Jan-2025 -
Initial patient assessment 15-Jan-2025 -
Development of individualized plan of care 15-Jan-2025 -
Plain X-ray of chest 20-Oct-2024 Suspected lung cancer (situation)
Assessment of health and social care needs 24-Jan-2018 -
Assessment of anxiety 24-Jan-2018 -
Assessment using AUDIT-C (Alcohol Use Disorders Identification Test - Consumption) 24-Jan-2018 -
Assessment of substance use 24-Jan-2018 -

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
Cow's milk 1961-04-22 active food Wheal (finding)
Mold 1961-04-22 active environment Allergic skin rash
Grass pollen 1961-04-22 active environment
House dust mite 1961-04-22 active environment
Animal dander 1961-04-22 active environment Rhinoconjunctivitis (disorder)<br> </br>Cough (finding)
Wheat 1961-04-22 active food
Allergy to substance 1961-04-22 active environment
Shellfish 1961-04-22 active food Anaphylaxis (disorder)<br> </br>Eruption of skin (disorder)
Tree pollen 1961-04-22 active environment

Care Plan

Active Planned Care / Goals Start Date Reason
Terminal care 16-Nov-2024 Non-small cell carcinoma of lung TNM stage 1 (disorder)
  • Ensure optimal comfort and symptom control for the patient during terminal care for non-small cell lung cancer (TNM stage 1).
  • Maintain pain at or below patient-defined acceptable level during terminal care.
  • Reduce severity of dyspnea to a tolerable level for the patient.
  • Minimize anxiety and psychological distress to improve quality of life during terminal care.
  • Ensure adequate psychosocial and spiritual support for the patient and family during terminal care.
Cancer care plan 29-Mar-2023 Neoplasm of prostate
  • Achieve remission or optimal control of prostate neoplasm to prevent further progression and metastasis
  • Maintain PSA at or below target threshold to monitor response to prostate cancer therapy
  • Minimize pain, urinary symptoms, and other complications related to prostate cancer and its metastases
  • Preserve or improve quality of life and functional status during cancer care
Care plan 21-Jan-2004 -
Musculoskeletal care 31-May-1986 -
Psychiatry care plan 14-Mar-1979 Major depression disorder
  • Patient will achieve remission of depressive symptoms as measured by PHQ-9 score.
  • Patient will report improved ability to perform activities of daily living and social engagement.
  • Patient will report no suicidal ideation or intent.
  • Patient will attend scheduled psychiatric appointments and adhere to prescribed medications.
Mental health care plan 21-Feb-1979 Major depression single episode
  • Patient will achieve remission of major depressive symptoms as measured by PHQ-9 score.
  • Patient will report improved ability to perform activities of daily living.
  • Patient will report no suicidal ideation.
Major depressive disorder clinical management plan 21-Feb-1979 Major depression disorder
  • Patient will achieve remission of depressive symptoms as measured by standardized depression scale.
  • Patient will report improved ability to perform activities of daily living and increased quality of life.
  • Patient will not experience suicidal ideation or engage in self-harm behaviors.
Self-care interventions 11-Apr-1961 -
Immunization Recommendation Due Date Reason
Vaccine product containing only Influenza virus antigen (medicinal product) 01-Oct-2025 Annual seasonal influenza vaccination

Vital Signs

Vital Signs 2025-06-22 2025-06-21
Pain severity - 0-10 verbal numeric rating [Score] - Reported 7 {score} 7 {score}

Relevant diagnostic tests/laboratory data

Recent Lab Observations 18-JUN-2025 Reference Range Unit
Glucose [Mass/volume] in Blood 87.7 70 - 99 mg/dL
Urea nitrogen [Mass/volume] in Blood 8.8 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 2.9 H 0.9 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 10.0 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 139.6 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.6 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 110.3 H 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 27.9 24 - 29 mmol/L
Protein [Mass/volume] in Serum or Plasma 7.1 6.6 - 8.3 g/dL
Albumin [Mass/volume] in Serum or Plasma 5.4 3.5 - 5.5 g/dL
Globulin [Mass/volume] in Serum by calculation 2.0 2 - 3.5 g/L
Bilirubin.total [Mass/volume] in Serum or Plasma 1.0 0.2 - 1.2 mg/dL
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 56.1 40 - 117 U/L
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 40.3 7 - 63 U/L
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 18.5 10 - 40 U/L
Appearance of Urine Cloudy urine
Odor of Urine Urine smell ammoniacal
Clarity of Urine Translucent
Color of Urine Brown color
Glucose [Mass/volume] in Urine by Test strip 1.2 H 0 - 0.8 mg/dL
Glucose [Presence] in Urine by Test strip ++
Bilirubin.total [Mass/volume] in Urine by Test strip 0.8 0 - 1 mg/dL
Bilirubin.total [Presence] in Urine by Test strip Finding of bilirubin in urine
Ketones [Mass/volume] in Urine by Test strip 5.1 H 0 - 4 mg/dL
Ketones [Presence] in Urine by Test strip Urine ketone test = +++
Specific gravity of Urine by Test strip 1.0 L 1.005 - 1.03 {nominal}
pH of Urine by Test strip 7.0 4.5 - 7.5 pH
Protein [Mass/volume] in Urine by Test strip 350.4 H 0 - 150 mg/dL
Protein [Presence] in Urine by Test strip Urine protein test = +++
Nitrite [Presence] in Urine by Test strip Urine nitrite negative
Hemoglobin [Presence] in Urine by Test strip Urine blood test = negative
Leukocyte esterase [Presence] in Urine by Test strip Urine leukocyte test negative
Leukocytes [#/volume] in Blood by Automated count 3.1 L 3.4 - 10.6 10*3/uL
Erythrocytes [#/volume] in Blood by Automated count 5.5 4.82 - 5.72 10*6/uL
Hemoglobin [Mass/volume] in Blood 12.1 L 13.5 - 17.5 g/dL
Hematocrit [Volume Fraction] of Blood by Automated count 39.0 37 - 52 %
MCV [Entitic volume] by Automated count 89.0 82 - 98 fL
MCH [Entitic mass] by Automated count 30.3 27 - 33 pg
MCHC [Mass/volume] by Automated count 35.9 32 - 37 g/dL
Erythrocyte distribution width [Entitic volume] by Automated count 41.5 39 - 55 fL
Platelets [#/volume] in Blood by Automated count 355.1 H 150 - 344 10*3/uL
Platelet distribution width [Entitic volume] in Blood by Automated count 455.5 H 13.4 - 17.4 fL
Platelet mean volume [Entitic volume] in Blood by Automated count 10.6 7.2 - 13.5 fL

Device Use

Device Date (since)
Home nebulizer (physical object) 26-May-1974